Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.
Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Yoshifuji K, et al. Among authors: yamada y. Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13. Int J Hematol. 2019. PMID: 30989487
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia.
Konishi T, Doki N, Nagata A, Yamada Y, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Konishi T, et al. Among authors: yamada y. Ann Hematol. 2020 Jan;99(1):147-155. doi: 10.1007/s00277-019-03865-x. Epub 2019 Nov 30. Ann Hematol. 2020. PMID: 31786646 Clinical Trial.
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation.
Kaito S, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Yoshifuji K, Mukae J, Akiyama M, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Ohashi K, Sakamaki H, Doki N. Kaito S, et al. Among authors: yamada y. Ann Hematol. 2020 Jul;99(7):1655-1665. doi: 10.1007/s00277-020-04089-0. Epub 2020 Jun 10. Ann Hematol. 2020. PMID: 32524200
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation.
Yamada Y, Konishi T, Nagata A, Toya T, Najima Y, Kobayashi T, Ohashi K, Doki N. Yamada Y, et al. Int J Hematol. 2022 Mar;115(3):449-451. doi: 10.1007/s12185-021-03234-3. Epub 2022 Jan 23. Int J Hematol. 2022. PMID: 35066800 No abstract available.
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.
Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K. Harada K, et al. Among authors: yamada y. Int J Hematol. 2016 Dec;104(6):709-719. doi: 10.1007/s12185-016-2085-0. Epub 2016 Aug 26. Int J Hematol. 2016. PMID: 27565504
Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission.
Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Konishi T, et al. Among authors: yamada y. Ann Hematol. 2019 Jul;98(7):1799-1801. doi: 10.1007/s00277-019-03668-0. Epub 2019 Mar 21. Ann Hematol. 2019. PMID: 30899981 No abstract available.
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation.
Kurosawa S, Doki N, Senoo Y, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Kurosawa S, et al. Among authors: yamada y. Ann Hematol. 2020 Aug;99(8):1873-1882. doi: 10.1007/s00277-020-04090-7. Epub 2020 May 25. Ann Hematol. 2020. PMID: 32451708 Clinical Trial.
Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.
Konishi T, Sekiya N, Otsuka Y, Konuma R, Wada A, Adachi H, Kishida Y, Nagata A, Yamada Y, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Konishi T, et al. Among authors: yamada y. Int J Hematol. 2021 Aug;114(2):263-270. doi: 10.1007/s12185-021-03146-2. Epub 2021 Apr 12. Int J Hematol. 2021. PMID: 33846960
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI.
Yamada Y, Ikegawa S, Najima Y, Atsuta Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Nagata A, Kaito S, Nagata R, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Yamada Y, et al. Int J Hematol. 2022 Feb;115(2):244-254. doi: 10.1007/s12185-021-03233-4. Epub 2021 Oct 15. Int J Hematol. 2022. PMID: 34652634
9,735 results